Enhanced SLC35B2/SAV1 sulfation axis promotes tumor growth by inhibiting Hippo signaling in HCC.
Bo HeZhao HuangSiyuan QinPeilan PengXirui DuanLongqin WangQin YeKui WangJingwen JiangBowen LiRui LiuCanhua HuangPublished in: Hepatology (Baltimore, Md.) (2024)
Our findings reveal a regulatory mechanism of the SLC35B2/SAV1 sulfation axis in response to oxidative stress, highlighting its potential as a promising therapeutic target for HCC.